CD19 and rheumatoid arthritis: In the RA subjects, TLR10 expression significantly increased with disease activity in both the CD19+CD27+ subset and the CD19+CD27− subset (P = 0.038 and P = 0.001, respectively) (Table 2 and Figure 3(b)).